Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.

Genomics - 1 Nov 2020

Samad Abdus, Jafar Tamanna, Rafi Jahirul Hasnat

Abstract excerpt

COVID-19 is a pandemic that began to spread worldwide caused by SARS-CoV-2. Lung cancer patients are more susceptible to SARS-CoV-2 infection. The SARS-CoV-2 enters into the host by the ACE2 receptor. Thus, ACE2 is the key to understand the mechanism of SARS-CoV-2 infection. However, the lack of knowledge about the biomarker of COVID-19 warrants the development of ACE2 biomarkers. The analysis of ACE2 expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Angiotensin-Converting Enzyme 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Computational Biology

Share to COVID-19

Share to Gene Expression Regulation, Neoplastic

Share to MicroRNAs

Share to Protein Interaction Maps

Source

Open in PubMed Open full text

Identifiers

PMID: 32916258
DOI: 10.1016/j.ygeno.2020.09.002
PMCID: PMC7831469

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.PMID 32916258Read ↗

Expression and Clinical Significance of SARS-CoV-2 Human Targets in Lung Tissues: Normal, Primary Tumor and MetastasisSemantic proximity Read ↗

Assessment of ACE2, CXCL10 and Their co-expressed Genes: An In-silico Approach to Evaluate the Susceptibility and Fatality of Lung Cancer Patients towards COVID-19 InfectionSemantic proximity Read ↗

Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancerSemantic proximity Read ↗

Association of ACE and ACE2 genes elevate the risk of lung cancerSemantic proximity Read ↗

ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19Semantic proximity Read ↗

A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targetsSemantic proximity Read ↗

ACE2: At the crossroad of COVID-19 and lung cancerSemantic proximity Read ↗

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infectionSemantic proximity Read ↗

Comprehensive Bioinformatics analysis of angiotensin-converting enzyme 2 (ACE2)Semantic proximity Read ↗

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19Semantic proximity Read ↗

The network of SARS-CoV-2—cancer molecular interactions and pathwaysSemantic proximity Read ↗

Analysis the susceptibility of lung cancer patients to SARS-CoV-2 infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.